Why Punjab’s Rs 84 Crore Orthopaedic Funding Scheme May Invite Judicial Review of Statutory Authority, Procedural Fairness and Transparency

The Punjab state government’s flagship health initiative known as Mukh Mantri Sehat Yojana has directed a financial outlay exceeding eighty‑four crore rupees towards orthopaedic interventions, including knee and hip replacements as well as fracture management, within a period of merely four months, signifying a rapid scaling of public health expenditure. The scheme’s emphasis on orthopaedic care has been accompanied by the introduction of cashless treatment facilities at both local primary health centres and tertiary hospitals, thereby expanding patient access to advanced surgical procedures without immediate out‑of‑pocket payment obligations. The rapid infusion of substantial public resources into orthopaedic services has transformed the medical landscape of the state, generating heightened demand for joint replacement surgeries and fracture repairs while also prompting health‑care providers to adapt infrastructure and staffing to accommodate the increased caseload. These developments raise several legal considerations regarding the statutory authority of the scheme, the procedural safeguards for beneficiaries, the accountability mechanisms for fund utilisation, and the potential for judicial review should the programme’s implementation contravene principles of natural justice or constitutional guarantees of health‑related rights. Moreover, the allocation of cashless facilities invokes questions about the regulatory framework governing public‑private partnerships in health care, the criteria for hospital accreditation under the scheme, and the transparency obligations imposed on the state to disclose selection processes and expenditure reports to ensure that public funds are deployed in accordance with fiduciary duties.

One fundamental legal question is whether the Punjab government possesses the legislative competence and statutory authority to allocate eighty‑four crore rupees specifically for orthopaedic interventions under the Mukh Mantri Sehat Yojana, a query that may require examination of the State List and Concurrent List provisions of the Constitution as well as any existing state health legislation granting such fiscal discretion. If the allocation is deemed ultra vires because the scheme is not grounded in a duly enacted state act or does not fall within the permissible scope of health‑related expenditures, the courts could invalidate the financial commitment or require legislative ratification before continued disbursement.

Another pressing issue concerns the procedural safeguards afforded to potential beneficiaries, because the determination of eligibility for cashless orthopaedic surgery under the scheme must adhere to principles of natural justice, including the right to a fair hearing and the obligation of the administering authority to publish clear, non‑discriminatory criteria. Should an applicant be denied cashless treatment without access to the reasons for denial or without an opportunity to contest the decision, the affected individual could invoke the right to be heard under Article 226 of the Constitution or seek remedial relief through a writ of certiorari alleging procedural impropriety.

A further dimension of legal scrutiny relates to the accountability mechanisms governing the expenditure of the eighty‑four crore rupees, because the state is obligated under the Right to Information Act to disclose details of fund allocation, hospital selection, and audit findings, thereby enabling public oversight and preventing arbitrary or corrupt disbursement of resources. If the authorities fail to publish the requisite information within the statutory time‑frames, interested parties may file a writ petition alleging violation of statutory duty and could obtain directions compelling compliance with transparency obligations.

The introduction of cashless orthopaedic services implicates the regulatory framework governing public‑private partnerships in health care, because hospitals participating in the scheme must obtain appropriate licences, meet quality accreditation standards, and adhere to pricing guidelines prescribed by the state health department to ensure that public funds are not misused. Failure to enforce these regulatory conditions could give rise to claims of illegal expenditure and may permit affected patients or consumer organisations to approach consumer courts under the Consumer Protection Act, seeking restitution or injunctions against non‑compliant hospitals.

In sum, the potential for judicial review emanates from multiple angles, including challenges to the statutory validity of the scheme, procedural deficiencies in beneficiary selection, non‑compliance with transparency statutes, and violations of constitutional guarantees of equality and health‑related rights, each of which may be addressed through writ petitions seeking declaration, mandamus or certiorari. A court assessing such petitions would weigh the evidentiary record presented by the petitioners, the State’s justification for the allocation, and the proportionality of the scheme’s impact on the rights of all citizens, potentially issuing interim orders to preserve the status quo while the substantive issues are resolved.